CFG Wealth Management Services »

Protagonist Therapeutics shares owned by CFG Wealth Management Services

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by CFG Wealth Management Services from 13F filings

Historical chart of CFG Wealth Management Services investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by CFG Wealth Management Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by CFG Wealth Management Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $64k 611 105.40
2025-12-31 $53k 602 87.34

More positions owned by CFG Wealth Management Services

Schwab U.s. Aggregate Bond Etf Uie (SCHZ)
Schwab International Equity Etf Uie (SCHF)
Schwab U.s. Broad Marketetf Uie (SCHB)
Invesco S&p 500 Low Volatility Etf Uie (SPLV)
Vanguard Total Bond Market Index Fund Etf Shares Uie (BND)
Schwab High Yield Bond Etf Uie (SCYB)
Schwab Emerging Markets Equity Etf Uie (SCHE)
Schwab Short-term U.s. Treasury Etf Uie (SCHO)
Schwab U.s. Small-cap Etf Uie (SCHA)
Schwab U.s. Large-cap Value Etf Uie (SCHV)
Schwab U.s. Mid-cap Etf Uie (SCHM)
Schwab U.s. Large-cap Growth Etf Uie (SCHG)
Spdr Bloomberg International Corporate Bond Etf Uie (IBND)
Spdr Bloomberg Short Term International Treasury Bond Etf Uie (BWZ)
Ishares Core U.s. Aggregate Bond Etf Uie (AGG)

View all positions for CFG Wealth Management Services

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
UBS Group
Rtw Investments
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Henderson Group
Johnson & Johnson
Invesco
Geode Capital Management
Citadel Advisors
Woodline Partners
Bank of America Corporation

View all funds holding Protagonist Therapeutics